Therefore, targeting drug-loaded NPs to specific cellular organelles, such as endosomes and lysosomes, can circumvent recognition by drug efflux pumps, like P-gp, through internalization by endocytosis, thus overcoming MDR in cancer cells. The gene discussed is PGP; the disease is cancer.